全文获取类型
收费全文 | 4090篇 |
免费 | 270篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 106篇 |
妇产科学 | 77篇 |
基础医学 | 556篇 |
口腔科学 | 76篇 |
临床医学 | 426篇 |
内科学 | 957篇 |
皮肤病学 | 57篇 |
神经病学 | 518篇 |
特种医学 | 62篇 |
外国民族医学 | 1篇 |
外科学 | 418篇 |
综合类 | 39篇 |
一般理论 | 1篇 |
预防医学 | 384篇 |
眼科学 | 41篇 |
药学 | 263篇 |
中国医学 | 6篇 |
肿瘤学 | 361篇 |
出版年
2024年 | 10篇 |
2023年 | 48篇 |
2022年 | 102篇 |
2021年 | 163篇 |
2020年 | 94篇 |
2019年 | 129篇 |
2018年 | 141篇 |
2017年 | 95篇 |
2016年 | 117篇 |
2015年 | 122篇 |
2014年 | 191篇 |
2013年 | 198篇 |
2012年 | 329篇 |
2011年 | 330篇 |
2010年 | 159篇 |
2009年 | 178篇 |
2008年 | 231篇 |
2007年 | 253篇 |
2006年 | 249篇 |
2005年 | 188篇 |
2004年 | 196篇 |
2003年 | 202篇 |
2002年 | 176篇 |
2001年 | 26篇 |
2000年 | 31篇 |
1999年 | 30篇 |
1998年 | 27篇 |
1997年 | 28篇 |
1996年 | 20篇 |
1995年 | 18篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1979年 | 9篇 |
1977年 | 9篇 |
1974年 | 10篇 |
1969年 | 14篇 |
1968年 | 13篇 |
1967年 | 9篇 |
排序方式: 共有4374条查询结果,搜索用时 2 毫秒
1.
Schneider Ralph Dettmer Marius Peters Nora Lamdark Tenzin Luedi Markus M. Adamina Michel Doll Dietrich 《European Surgery》2022,54(2):117-125
European Surgery - Treatment of pilonidal sinus disease (PSD) requires a tailored approach. A national guideline was published in 2014. The current status of surgical PSD therapy... 相似文献
2.
3.
Twenty one patients with idiopathic Parkinsonism beginning before the age of 40 years were investigated. The mean duration of the disease was 19 years. There was a good and sustained response to levodopa. Only four patients reached stages IV and V (Hoehn and Yahr). Intolerance to levodopa was observed in the more advanced stages of the disease. In the series the familial incidence of Parkinsonism (2 cases) and essential tremor (3 cases) was very low. Thyroid disorder, diabetes mellitus or macrocytic anaemia was not found in any of the cases. 相似文献
4.
5.
INLANDER, CHARLES B., LEVIN, LOWELL B., AND WEINER, E.D. Medicine on Trial: The Appalling Story of Medical Ineptitude and the Arrogance that Overlooks It. 相似文献
6.
Christopher D Wells Russell I Heigh Virender K Sharma Michael D Crowell Suryakanth R Gurudu Jonathan A Leighton Nora Mattek David E Fleischer 《BMC gastroenterology》2007,7(1):19
Background
Many factors impacting cecal intubation rates have been examined in detail; however, little information exists regarding the effect of the timing of the procedure. We sought to examine any difference in cecal intubation rates between morning and afternoon colonoscopies and identify factors contributing to a discrepancy. 相似文献7.
Risk of death from acute pancreatitis 总被引:5,自引:0,他引:5
Giorgio Talamini Claudio Bassi Massimo Falconi Nora Sartori Luca Frulloni Vincenzo Di Francesco Sergio Vesentini Paolo Pederzoli Giorgio Cavallini 《Journal of gastrointestinal cancer》1996,19(1):15-24
Summary
Conclusions
The analysis of all the data available in 192 patients at 24 h from admission shows that only serum glucose above 250 mg/dL
(13.88 mmol/L) and serum creatinine above 2 mg/dL (176.8 μmol/L) are prognostic factors of death (P<0.0001). When, however, pathological chest X-rays are also considered in a subset of 149 patients, these and serum creatinine
are prognostic factors of death with odds ratios of 2.9 (95% CL 1.3–6.3) and 9.4 (95% CL 2.2–40.7), respectively (P<0.0001).
Background In patients suffering from acute pancreatitis, neither Ranson scores nor Glasgow criteria evaluation at 24 h yield a sufficiently
reliable prognosis of the risk of death from the first acute attack.
Methods After excluding posttraumatic, postsurgical, and post-ERCP acute pancreatitis, we selected 192 consecutive patients admitted
in the first instance to our center for a first attack, distinguishing between patients who died and patients who survived.
We used Cox's model to analyze the prognostic weight of variables available within 24 h of admission (sex, age, alcohol intake,
smoking habits, 17 biochemical tests, body mass index, chest X-rays, body temperature, and shock status).
Results Seventeen (8.8%) patients died; mortality showed a decreasing trend over the period of years considered and was correlated,
among other things, with necrotizing type of pancreatitis, idiopathic etiology, and shock status on admission. 相似文献
8.
9.
Alex Y. Chang Z. Nora Tu Julia L. Smith Philip Bonomi Thomas J. Smith Peter H. Wiernik Ronald Blum 《Investigational new drugs》1995,13(2):137-141
Summary Fifty-five patients with metastatic non-small cell lung cancer (NSCLC) were entered into this phase II randomized study for evaluating three new agents: gallium nitrate, amonafide and teniposide. The patients had to have ECOG performance status 0 or 1, no prior chemotherapy, and adequate hematological, hepatic and renal functions. Forty-seven patients were eligible and evaluable. Fourteen were randomized to receive gallium nitrate, 18 to amonafide and 15 to teniposide. Seventy-four percent of eligible patients were male. The majority of patients (89%) had an ECOG performance status 1. ECOG grade 4 toxicity occurred twice in patients on gallium nitrate, seven times on amonafide and 18 times on teniposide. The cause of death was attributed to amonafide in one patient (from sepsis) and to teniposide in two patients (due to infection and leukopenia). There was no objective response in all the patients entered. The overall survival times ranged from 2 weeks to 156 weeks with a median of 23 weeks. There were no survival differences among the three treatment arms. We conclude that gallium nitrate, amonafide and teniposide are inactive in metastatic NSCLC and do not warrant any further testing in this disease.The contents of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. 相似文献
10.